Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients' variants.
Khawaja T, Kajova M, Levonen I, Pietilä JP, Välimaa H, Paajanen J, Pakkanen SH, Patjas A, Montonen R, Miettinen S, Virtanen J, Smura T, Sironen T, Fagerlund R, Ugurlu H, Iheozor-Ejiofor R, Saksela K, Vahlberg T, Ranki A, Vierikko A, Ihalainen J, Vapalahti O, Kantele A.
Khawaja T, et al. Among authors: ranki a.
Infect Dis (Lond). 2024 Jun;56(6):423-433. doi: 10.1080/23744235.2024.2329957. Epub 2024 Mar 21.
Infect Dis (Lond). 2024.
PMID: 38513074
Free article.